Table 2.
Study | Eyes/patients (n) | CNV status | OCT | Agreement FA-OCT based on | Sensitivity (%) | Specificity (%) |
---|---|---|---|---|---|---|
Salinas-Alamán et al.82 | 62 eyes | Naive PDT-t | TD | SRF, IRF | 97 | n.a. |
TD | SRF, IRF | 96 | 59 | |||
Sandhu and Talks83 | 131 eyes | Naïve | TD | CNV, SRF, IRF, PED | 96 | 66 |
Eter and Spaide84 | 60 eyes | PDT-t | TD | SRF, IRF | 80 | 80 |
Van de Moere et al.85 | 121 eyes | PDT-t | TD | SRF | 41 | 83 |
IRF | 83 | 53 | ||||
Gross CMO | 23 | 96 | ||||
Solitary foveal cyst | 13 | 75 | ||||
CRT | 63 | 82 | ||||
van Velthoven et al.86 | 30 pts | PDT-t | TD | CMO, SRF, CRT | 65 | 43 |
Talks et al.87 | 134 pts | Naive | TD | Findings of nAMD | 100 | 65 |
Malamos et al.88 | 37 pts | Naive | SD | CNV, SRF, IRF, PED, CRT | n.a. | n.a. |
Henschel et al.89 | 14 pts | PDT-t | TD | SRF | 71 | 70 |
IRF | 90 | 40 | ||||
SRF, IRF | 97 | 37 | ||||
Khurana et al.90 | 59 eyes | IV-t | TD | SRF, IRF | 59 | 63 |
SD | SRF, IRF | 90 | 47 | |||
Giani et al.91 | 93 pts | Naïve | SD | SRF | 68 | 88 |
SRF, IRF, PED | 94 | 27 | ||||
Padnick-Silver et al.92 | 79 pts | Naïve | TD | SRF, IRF, PED | 80 | 93 |
Do et al.93 | 87 pts | Naive | TD | SRF, IRF, CRT | 69 | 57 |
Wilde et al.94 | 411 pts | Naive | SD | SRF, IRF, PED | 100 | 80 |
Castillo et al.78 | 400 pts | Mixed | TD/SD | Meta analysis | 85 | 48 |
CMO, cystoid macular edema; CRT, central retinal thickness; IV-t, IV treated; n.a., not applicable; nAMD, neovascular AMD; PED, pigment epithelium detachment; PDT-t, PDT-treated; pts, patients.